Physician profile
Brandon M Eck
NPI 1073923496
$1,222.52
in general payments reported to CMS, 2019-2025
21 companies · $57.52 in 2025
The $57.52 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $944 · 2020: $191 · 2022: $16.46 · 2023: $13.92 · 2025: $57.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $71.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $71.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $216.68 | 2019-2020 | |
| Bioventus LLC | $185.05 | 2019-2023 | Durolane |
| Sanofi-Aventis U.S. LLC | $87.00 | 2019-2020 | |
| Nevro Corp. | $85.51 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $82.87 | 2019-2020 | |
| Depuy Synthes Sales INC. | $82.85 | 2019-2020 | |
| Amgen INC. | $76.56 | 2019 | |
| Merz North America, INC. | $53.11 | 2019 | |
| Electronic Waveform Lab, INC. | $46.72 | 2019 | |
| Si-Bone, INC. | $46.02 | 2019 | |
| Ferring Pharmaceuticals INC. | $41.88 | 2025 | Euflexxa |
| Collegium Pharmaceutical, INC. | $40.17 | 2020 | |
| Arbor Pharmaceuticals, INC. | $38.32 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $23.35 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $22.92 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arteriocyte Medical Systems, INC. | $21.01 | 2019 | |
| Scilex Pharmaceuticals INC. | $16.48 | 2019 | |
| Novo Nordisk INC | $15.64 | 2025 | Ozempic |
| Radius Health, INC. | $14.95 | 2019 | |
| Forte Bio-Pharma LLC | $14.41 | 2020 | |
| Pfizer INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Eck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.